Abnova/A2ML1 293T细胞瞬时过表达裂解物（变性）/1kit/H00144568-T01
商品编号：
H00144568-T01
品牌：
abnovadx
市场价：
¥0.00
美元价：
0.00
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
- Specification
- Transfected Cell Line:
- 293T
- Plasmid:
- pCMV-A2ML1 full-length
- Host:
- Human
- Theoretical MW (kDa):
- 17.49
- Quality Control Testing:
- Transient overexpression cell lysate was tested with Anti-A2ML1 antibody (H00144568-B01) by Western Blots.SDS-PAGE Gel
A2ML1 transfected lysate.Western Blot
Lane 1: A2ML1 transfected lysate ( 17.49 KDa) Lane 2: Non-transfected lysate.
- Storage Buffer:
- 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
- Storage Instruction:
- Store at -80°C. Aliquot to avoid repeated freezing and thawing.
- MSDS:
Download
- Datasheet:
- Download
- Applications
- Western Blot
- Application Image
- Western Blot
- Gene Information
- Entrez GeneID:
- 144568
- GeneBank Accession#:
- BC093840.1
- Protein Accession#:
- AAH93840.1
- Gene Name:
- A2ML1
- Gene Alias:
- CPAMD9,DKFZp686C1729,DKFZp686D2011,DKFZp686G1812,DKFZp686L1821,DKFZp686O1010,FLJ16045,FLJ25179,FLJ39129,FLJ41597,FLJ41598,FLJ41607
- Gene Description:
- alpha-2-macroglobulin-like 1
- Omim ID:
- 610627
- Gene Ontology:
- Hyperlink
- Gene Summary:
- The alpha-macroglobulin (AM) superfamily of proteins contains both complement components and protease inhibitors, including A2M (MIM 103950) and A2ML1. AM proteins display a unique trap mechanism of inhibition, by which the AM inhibitor undergoes a major conformational change upon its cleavage by a protease, thus trapping the protease and blocking it from subsequent substrate binding (Galliano et al., 2006 [PubMed 16298998]).[supplied by OMIM
- Other Designations:
- C3 and PZP-like, alpha-2-macroglobulin domain containing 9,OTTHUMP00000158614
- Related Disease
- Alzheimer Disease
- Alzheimer disease
- Cerebral Amyloid Angiopathy
- Genetic Predisposition to Disease
- Neuroblastoma
品牌介绍
Abnova是世界上最大的抗体制造商。亚诺法的所有产品，重组蛋白和抗体都是利用最新的技术及由SPF等级动物实验室制造生产出来。我们的目标是生产人类基因组内每个基因至少要有一个相对应的抗体，可以提供给来自于学术机构、行业的伙伴和合作者做研究。亚诺法有许多多样化的单克隆及多克隆抗体，我们更进一步开发一系列的整合系统与相关应用包含配对抗体、ELISA试剂盒与荧光原位杂交(FISH)探针。这些工具对生物标记开发与转译研究都是必须的。亚诺法亦有针对糖尿病、传染疾病与癌症的体外检验试剂专案以及用于治疗败血症的全人类抗体药技专案，为全人类的健康努力。
联络我们
